Cytomegalovirus (CMV) is a virus of low infectivity belonging to the herpesvirus family. It is the main culprit of congenital morbidity and mortality in children. Congenital infections are very common and are asymptomatic in most cases, and their importance lies in their potential severity for neonates and immunosuppressed patients.
In this lesson we will study the features of congenital cytomegalovirus infection, its symptoms, diagnosis and treatment.

Remember that this lesson is part of the free courses from Paradigmia. Access the full course below 👇👇 PAEDIATRICS COURSE
Epidemiology of congenital or neonatal cytomegalovirus
- The incidence is 0.14-1% of live-born newborns. It is the most common congenital infection.
- If there is a primary maternal infection the risk is higher (30-40%) than with a recurrent infection (<1%). Remember that in primary infection the characteristic symptoms in the mother are a flu-like illness.
- Serological screening for CMV in pregnant women is not recommended (we will see this later in the section on diagnosis).

Clinical forms of congenital cytomegalovirus
- 90% are subclinical. They cause sensorineural hearing loss as a sequela (up to 53% of cases are left with this sequela). This is the most common form of presentation. We must suspect congenital CMV infection in every child who fails the hearing screen, and to confirm or exclude the infection we request serology (we must also suspect it in very low birth weight infants who do not gain weight). They may also be left with mild intellectual disability.
- 5% very mild involvement with a single symptom, almost silent.
- 5% severe: “cytomegalic inclusion disease”, the earlier in pregnancy the infection occurs, the greater the severity.
Clinical features of cytomegalovirus in the newborn
Some of the manifestations produced by congenital cytomegalovirus infection are:
- Hepatosplenomegaly. In 60% of cases there is raised transaminases and cholestasis.
- Jaundice: 50%, with direct bilirubin predominating.
- Purpuric rash and petechiae.
- Thrombocytopenia (also in rubella): 20,000 – 60,000 platelets. It takes 3-4 weeks to recover.
- Meningoencephalitis: there is raised CSF protein.
- Lethargy, hypotonia, seizures.
- Microcephaly and periventricular intracranial calcifications (to be distinguished from toxoplasmosis, which has diffuse calcifications). (IMPORTANT) This is the most characteristic finding of this infection.
- Chorioretinitis.
- Sensorineural hearing loss (15 to 53% of those infected)
- IUGR and prematurity.
- Pneumonitis

Remember 💙 the CMV RULE
C (Chorioretinitis, acalculous cholecystitis), M (Microcephaly) and V (periVentricular calcifications)
Sequelae of congenital cytomegalovirus
Some of the sequelae resulting from CMV infection are:
- Sensorineural hearing loss
- Abnormal psychomotor development due to micrencephaly
- Seizures.
In every newborn with growth retardation or who fails the hearing loss screen, congenital CMV infection must be excluded.
Remember that this lesson is part of the free courses from Paradigmia. Access the full course below 👇👇 PAEDIATRICS COURSE
Diagnosis of congenital CMV
Suspicion should arise in a newborn or neonate with:
- Jaundice
- Hepatosplenomegaly
- Petechiae
- Microcephaly
- Cerebral calcifications.
For confirmation in the newborn we use:
- Histology: cells with inclusion bodies in liver and lung tissue.
- Cytology: inclusion bodies in urinary sediment, saliva or CSF (20-25%). A negative result does not mean the infection is absent.
- Virology: virus culture (urine, saliva, CSF and biopsy tissue samples) in the first two weeks of life. Rapid culture techniques are now used.
- Serology:
- High, stable anti-CMV IgG titre during the first 6 months of age (this is not used in current clinical practice, because it takes too long).
- Anti-CMV IgM antibodies in the newborn (poorly sensitive and poorly specific).
- DNA analysis by PCR: in amniotic fluid or blood (we can even use dried blood, such as the blood left over from the heel-prick test).
- Remember that in primary infection the characteristic symptoms in the mother are a flu-like illness.
We will summarise the diagnostic techniques in the following table:

The most widely used method at present is PCR/serological determination of the virus or detection of the virus in the newborn by culture. Screening is not indicated in mothers.
Indications for postnatal CMV testing
The indications for postnatal CMV testing are summarised in the following image.

Treatment of congenital cytomegalovirus (CMV) infection
Treatment of the infection should be given to the newborn, not to the mother. This is because mothers are not usually screened and so maternal infection is not detected. We will give:
- Ganciclovir: reduces the viral load and the incidence of hearing loss. The blood count of these patients must be monitored because of the risk of leucopenia (beware of nosocomial infections).
- Dose: 12mg/kg/d for 6 weeks intravenously.
- It is started even before a definitive diagnosis because the sooner the better; it greatly reduces the development of hearing loss, although lesions that have already occurred cannot be reversed.
- Oral valganciclovir: we use it in cases of leucopenia due to ganciclovir. In many cases treatment is started with intravenous ganciclovir and after a few weeks it is changed to valganciclovir, because of the risk of leucopenia.
- Dose: 32 mg/kg/day orally, 6 weeks.
- Foscarnet: if the above cannot be used.
Remember that this lesson is part of the free courses from Paradigmia. Access the full course below 👇👇 PAEDIATRICS COURSE